‘Under pressure’: The role of therapeutic drug monitoring in the treatment of hypertension

Jorie Versmissen, Job van Steenkiste, Birgit C.P. Koch, Laura E.J. Peeters*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Antihypertensive drugs do not qualify as optimal candidates for therapeutic drug monitoring (TDM), given their obvious physiological effect, the absence of a clear relationship between drug concentrations and pharmacodynamic outcomes and their wide therapeutic range. However, since non-adherence is a major challenge in hypertension management, using drug concentrations can be of value to identify non-adherence as a first step towards better blood pressure control. In this article we discuss the key challenges associated with measuring and interpreting antihypertensive drug concentrations that are important when TDM is used to improve non-adherence. Additionally, we elaborate on the role of TDM in optimizing antihypertensive drug treatment besides addressing non-adherence by highlighting its value in specific patient groups with altered pharmacokinetic parameters such as female vs. male or elderly patients.

Original languageEnglish
Number of pages8
JournalBritish Journal of Clinical Pharmacology
Publication statusE-pub ahead of print - 2024


  • adherence
  • antihypertensive drugs
  • hypertension
  • therapeutic drug monitoring


Dive into the research topics of '‘Under pressure’: The role of therapeutic drug monitoring in the treatment of hypertension'. Together they form a unique fingerprint.

Cite this